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Abstract
Introduction: N-acetylcysteine has proven to be effective in paracetamol intoxications, but there is
no consensus regarding its way of administration. Here, we report a case to highlight the importance
of careful management of intravenous n-acetylcysteine.
Case presentation: A two-month old infant was seen in our paediatric emergency department due
to paracetamol poisoning after repeated supratherapeutic doses. She was treated with intravenous
n-acetylcysteine diluted with dextrose 5%, according to the 20-hour standard protocol. Eight hours
later she developed two tonic-clonic seizures and was subsequently intubated. By that time, she had
received almost 1 liter of 5% dextrose, and serum sodium was 114 mg/dL. A rapid correction was
done with hypertonic saline and the child experienced a good outcome, without any sequelae.
Conclusion: Intravenous n-acetylcysteine administration must be done carefully. Amount of liquid
administrated and sodium monitoring should be kept in mind, with special care in small children.
Introduction
Paracetamol is a worldwide-used, safe and effective
antipyretic and analgesic for children when used at
therapeutic doses. It is nowadays the leading cause of
drug poisoning among young children [1]. Repeated
supratherapeutic doses with non self-harming intent is
an increasing type of paracetamol intoxication, both in
adult and paediatric patients [2].
This medication achieves its highest serum levels about
four hours after ingestion [3]. Serum paracetamol level
determination should be performed at that time if
ingested amount is over 150 to 200 mg/kg in a single
dose [4,5]. If the value is above the study line of Rumack-
Matthew nomogram [6], N-acetylcysteine (NAC) must be
administered, either intravenously or orally. Activated
charcoal is useful to lower intestinal absorption when
ingestion takes place within the previous 60 to 90 minutes
[3,7].
Here, we present a case, which derived in a life-threatening
condition in an infant due to intravenous administration
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of NAC. We also discuss the use of NAC so as to avoid
complications in small children.
Case presentation
A two-month old Caucasian Spanish infant was seen in
our pediatric emergency department (PED) because of
paracetamol overdosing. She was febrile due to vaccina-
tion and her parents gave her three consecutive doses of
500 mg instead of 50 mg of paracetamol (weight 4.7 kg),
separated by 6 hours. The infant was brought to our PED
two hours after the last dose.
Plasma paracetamol level was determined on arrival
(113.5 µg/mL). The child was admitted to the ward and
intravenous NAC infusion was started following the
standard 20-hour protocol as paracetamol level was high
(Table 1).
Eight hours later, the child presented a 2-minutes
generalized seizure which responded to intravenous
diazepam. Fifteen minutes later, she had another tonic-
clonic seizure which also responded to diazepam after
6 minutes. Due to impaired consciousness and suspicion
of liver encephalopathy she was intubated and transferred
to the pediatric intensive care unit. Blood analysis showed
hyponatremia of 114 mEq/L, which was managed with a
rapid correction of hypertonic saline until the serum
sodium reached 124 mmol/l. Then, sodium was gradually
increased via isotonic saline and furosemide boluses.
Paracetamol levels were undetectable by 15 hours after
admission (Table 1).
The girl was extubated ten hours later, and evoluted
satisfactorily. She was followed up as an outpatient during
the following months, and her neurological status was
completely normal.
Discussion
Paracetamol poisoning is the main cause of acute liver
failure in adult patients in the West World. In children,
paracetamol has fewer toxic effects, but due to its wide use,
it remains a concern nowadays. The risk of hepatoxicity is
higher in repeated supratherapeutic doses administration
than in single overdose [8]. A frequent mistake in pediatric
dose administration is made when the parents miscalcu-
late the appropriate dose or when there is confusion with
paracetamol concentration due to different presentations
of the same product [9]. In our case, dosage was ten times
higher than the right one [10].
NAC is useful as an antidote for paracetamol overdosing as
it increases gluthatione, which binds and inactivates the
hepatotoxic metabolite N-acetyl-p-benzoquinoneimine. It
is indicated when paracetamol plasma concentration is
above the study line of Rumack-Matthew nomogram in
single overdoses [6]. If time of ingestion is not known or if
the patient received repeated supratherapeutic doses,
correct risk-stratification cannot be done with the use of
Rumack-Matthew nomogram. In those cases, it seems
prudent to administer NAC if serum paracetamol con-
centration is over 20 µg/ml [11]. Moreover, delayed NAC
administration has been identified as one of the risk
factors to a worse outcome [12]. According to this, the
decision of prescribing NAC to our child was correct.
There is no consensus regarding NAC administration as it
seems to be effective if used both intravenously and orally
[7,12,13]. Some advantages for intravenous administra-
tion are that it can be used in patients at risk of impaired
consciousness and its shorter duration when compared to
oral one. Oral dose of n-acetylcysteine involves a large
volume and would greatly increase the risk of regurgitation
and aspiration, mostly if liver failure develops which could
impair conscious level.
Protocols as the 20-hour one used in our case must be
abandoned in small patients for intravenous NAC admin-
istration. According to them, patients are given a loading
dose of 150 mg/kg of NAC in 40 to 200 ml of 5% dextrose
over 15 minutes, followed by 50 mg/kg in 500 ml of 5%
dextrose over 4 hours and then 100 mg/kg in 1000 ml of
5% dextrose over the next 16 hours. By eight hours of
treatment, our child had received 950 mL of 5% dextrose.
If the protocol would have been completed, she would
have received up to 361.7 ml/kg of free water. Therefore,
NAC concentration should be of 40 mg of NAC per ml of
5% dextrose [11,14] or drug information sheet for patients
weighting 10 kg should be followed (Acetadote®). This
should avoid complications as cerebral edema or hypona-
tremia [14].
In conclusion, intravenous NAC administration must be
done carefully. Amount of liquid administrated and
sodium monitoring should be kept in mind, with special
care in small children.
Consent
Written informed consent was obtained from the patient
parents’ for publication of this case report. A copy of the
Table 1. Blood determinations at admission (PED), at the time seizures
developed (WARD) and after rapid correction with hypertonic saline in
the pediatric intensive care unit. PED: pediatric emergency department;
PICU: pediatric intensive care unit
PED WARD PICU
Glucose (mg/dl) 117 290 137
Sodium (mg/dl) 134 114 124
AST (U/l) 64 57 61
ALT (U/l) 39 36 38
Serum paracetamol level (µg/mL) 113.5 17.8 7.8
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written consent is available for review by the Editor-in-
Chief of this journal.
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